Inhaled IRK inhibitors as a novel therapeutic for IPF
Ended Project Grant Awarded
- Award ID
- R44HL151067
- Recipient
-
Metera Pharmaceuticals Inc. UEI NUVXLC5FAYJ3
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,515,600
Award facts
- Assistance listing
- 93.838 Lung Diseases Research
- Completion date
- Place of performance
- West Somerville, MA 02144, USA
Award details come from USAspending.gov.
Quick answers
Who received award R44HL151067?
R44HL151067 was awarded to Metera Pharmaceuticals Inc. by National Heart Lung and Blood Institute (National Institutes of Health) on February 10, 2020.
How much is award R44HL151067 worth?
$1,515,600 has been obligated on R44HL151067.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award